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superior predictor of all-cause mortality in patients
with systolic heart failure and atrial ﬁbrillation
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Abstract
Aims Quantiﬁcation of systolic function in patients with atrial ﬁbrillation (AF) is challenging. A novel approach, based on RR
interval correction, to counteract the varying heart cycle lengths in AF has recently been proposed. Whether this method is
superior in patients with systolic heart failure (HFrEF) with AF remains unknown. This study investigates the prognostic value
of RR interval-corrected peak global longitudinal strain {GLSc = GLS/[RR^(1/2)]} in relation to all-cause mortality in HFrEF pa-
tients displaying AF during echocardiographic examination.
Methods and results Echocardiograms from 151 patients with HFrEF and AF during examination were analysed ofﬂine. Peak
global longitudinal strain (GLS) was averaged from 18 myocardial segments obtained from three apical views. GLS was indexed
with the square root of the RR interval {GLSc = GLS/[RR^(1/2)]}. Endpoint was all-cause mortality. During a median follow-up of
2.7 years, 40 patients (26.5%) died. Neither uncorrected GLS (P = 0.056) nor left ventricular ejection fraction (P = 0.053) was
signiﬁcantly associated with all-cause mortality. After RR^(1/2) indexation, GLSc became a signiﬁcant predictor of all-cause
mortality (hazard ratio 1.16, 95% conﬁdence interval 1.02–1.22, P = 0.014, per %/s^(1/2) decrease). GLSc remained an inde-
pendent predictor of mortality after multivariable adjustment (age, sex, mean heart rate, mean arterial blood pressure, left
atrial volume index, and E/e0) (hazard ratio 1.17, 95% conﬁdence interval 1.05–1.31, P = 0.005 per %/s^(1/2) decrease).
Conclusions Decreasing {GLSc = GLS/[RR^(1/2)]}, but not uncorrected GLS nor left ventricular ejection fraction, was signiﬁ-
cantly associated with increased risk of all-cause mortality in HFrEF patients with AF and remained an independent predictor
after multivariable adjustment.
Keywords Global longitudinal strain; Heart failure with reduced ejection fraction; Atrial ﬁbrillation; Speckle tracking; Risk
stratiﬁcation
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Introduction
Echocardiographic quantiﬁcation of left ventricular (LV) sys-
tolic function in heart failure (HF) patients has improved sur-
vival rates as a result of better and intensiﬁed medical
treatment.1,2 It has previously been shown that atrial ﬁbrilla-
tion (AF) modiﬁes and incapacitates the predictive value of
several echocardiographic parameters normally used to asses
LV function.3 New methods for echocardiographic risk
stratiﬁcation in patients displaying AF at examination are
therefore needed.
Quantiﬁcation of LV function presents a challenge in AF pa-
tients due to a variety of factors: elevated heart rate, greatly
increased beat-to-beat duration variability (RR interval), and
absence of atrial contraction (usually measured as late
diastolic velocities: A, a0). All signiﬁcantly disrupt routine
echocardiographic usability. These difﬁculties often result in
exclusion of AF patients from echocardiographic studies or
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in a limited inclusion of patients only displaying low RR
variability.
Myocardial strain parameters have shown proﬁciency in
predicting outcome and quantifying LV function in several pa-
tient groups, a few of these being ischaemic heart disease,4
HF with reduced ejection fraction (HFrEF),3 and HF with pre-
served ejection fraction.5 Our group has recently demon-
strated peak global longitudinal strain (GLS) to be a superior
prognosticator of all-cause mortality in patients with HFrEF.3
Despite these results, no prognostic value of GLS was found
in HFrEF patients displaying AF at examination. This calls for
further research into markers of signiﬁcant prognostic value
in patients with AF.
The widely accepted method to overcome the varying RR
interval observed in AF is presently to obtain echocardio-
graphic imaging and parameters from preferentially 10–15
consecutive heart cycles, with subsequent averaging of
values to obtain parameters somewhat representative of true
LV function.6 This is highly impractical in a busy clinical set-
ting and may therefore result in poor echocardiographic as-
sessment of patients displaying AF. Recently, a novel
method to counteract the varying cycle length observed in
AF has been proposed.7 This strategy is based on correction
of the strain parameters by the square root of the particular
RR interval in which the measurements were made, a strat-
egy also employed in QT-interval correction (Bazett’s for-
mula). Correction by RR interval has been suggested as a
superior method compared with averaging of several heart
cycles.7,8 The same method has been demonstrated to be
successful in predicting outcome in patients with AF through
correction of GLS by the square root of RR.9
In light of presented information, this study evaluates the
predictive value of GLS, GLSc, peak global circumferential
strain (GCS), and corrected GCS (GCSc) in HFrEF patients with
AF during examination in comparison with conventional
echocardiographic parameters.
Methods
Data
The Department of Cardiology, Herlev & Gentofte Hospital,
University of Copenhagen, conducts routine echocardio-
graphic assessments according to a standardized protocol.3,7
Results have been stored in a local hard drive since 2005.
Study population
This retrospective study included echocardiographic exami-
nations from 151 HFrEF patients with AF. The identiﬁcation
of the HFrEF population for this study has been described in
detail elsewhere.3 Brieﬂy, patients were selected from a
population of non-acute HFrEF patients referred to the HF
clinic at Gentofte University Hospital from 2005 to 2013.3
Only patients with an LV ejection fraction (LVEF) <45% were
considered. Only patients who presented with AF during
echocardiographic examination and a frame rate adequate
for strain analysis (≥45 frames per second) were considered.
Baseline clinical characteristics were retrieved from the HFrEF
database and were originally recorded by the clinic at the ﬁrst
visit. All patients had been diagnosed with HFrEF by an expe-
rienced clinician. Mortality status information was retrieved
from the Danish National Registry of Mortality at follow-up,
and follow-up was 100%. Ischaemic cardiomyopathy was de-
ﬁned as patients having a history of myocardial infarction
and/or having undergone percutaneous transluminal coro-
nary angioplasty or coronary artery bypass graft surgery.
Echocardiography
All echocardiographic assessments were obtained through ei-
ther Vivid 7 or 9 echocardiographic machines (GE Healthcare,
Horten, Norway) and stored in a GE Healthcare Image Vault.
Analysis of echocardiographic data was subsequently per-
formed ofﬂine by a single investigator blinded to all patient
data by use of Echopac version 12 (GE Healthcare).
Conventional
Left ventricular ejection fraction was calculated using the
modiﬁed Simpson biplane method from the apical
four-chamber and two-chamber views.10 Therefore, LVEF cal-
culation was derived from two cardiac cycles. LV end-diastolic
dimensions were measured in the parasternal long-axis view
at the tip of the mitral valve leaﬂets. Parameters measured
include interventricular septal thickness, LV posterior wall di-
mensions, and LV internal dimensions.10
LV mass was estimated using the Devereux formula.11 Fur-
thermore, LV mass was divided by body surface area to ob-
tain the LV mass index. Estimation of body surface area was
obtained through use of the Du Bois formula.12 Left atrial vol-
ume was obtained by the biplane area length method and
left atrial volume index (LAVI) by division with body surface
area.10
The tricuspid annular plane systolic excursion (TAPSE) was
measured through M-mode echocardiography in the apical
four-chamber view, placing the M-mode cursor on the lateral
tricuspid annulus.
Pulsed-wave Doppler analysis in the apical four-chamber
view was used to evaluate diastolic mitral inﬂow patterns
and measure peak early transmitral inﬂow velocity (E) and
deceleration time of the early diastolic inﬂow. Pulsed-wave
tissue Doppler imaging analysis with region of interest (ROI)
positioned in the lateral and septal part of the mitral annulus
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in the apical four-chamber view was used to determine peak
longitudinal tissue velocity during early diastolic ﬁlling (e0). A
mean e0 between the septal and lateral velocity was calcu-
lated, and E was indexed by e0 to yield a representation of ﬁll-
ing pressure during diastole (E/e0).
Speckle tracking echocardiography
Longitudinal speckle tracking analysis in a single heart cycle
was performed in the apical four-chamber view, apical two-
chamber view, and apical long-axis view; and GLS was aver-
aged from a total of 18 myocardial segments. Therefore,
GLS was derived from three heart cycles, one from each view.
GCS was averaged from six myocardial segments obtained
from the parasternal short-axis view at mid-ventricular level.
For both longitudinal and circumferential analyses, the endo-
cardial border was manually deﬁned by point and click by the
investigator at end-systole, with subsequent automatic de-
tection of the epicardial border; hence, the ﬁnal ROI was gen-
erated as the result of a semi-automated process. Before
acceptance of ROI, the investigator visually inspected each
myocardial segment in all views for acceptable tracking of
speckles and either accepted or rejected each segment based
on this assessment. If segmental tracking was deemed inade-
quate, attempts to correct the ROI in this particular segment
were made by the investigator by manual adjustment. In case
of persistent unacceptable tracking, the particular segment
was excluded. In case of shadowing of a myocardial segment
by an artefact, the segment was excluded. Furthermore, aor-
tic valve closure was visually assessed by the investigator.
In order to adjust for the varying heart cycle interval ob-
served in AF rhythm, correction by the square root of the
RR interval was used to index values of both GLS and GCS,
hereby obtaining GLSc {GLSc = GLS/[RR^(1/2)]} and GCSc
{GCSc = GCS/[RR^(1/2)]}.
Statistical analysis
All statistical analyses were performed using STATA version
13.0 on Mac OS. Statistical signiﬁcance was deﬁned as
P < 0.05. Continuous Gaussian distributed variables were
compared using two-tailed Student’s t-test, while categorical
variables were compared through use of the χ2 test. In case
of mean comparison between more than two groups, one-
way ANOVA with subsequent post hoc analysis (Scheffe)
was used. To analyse trend, linear regressions of means were
performed. Survival curves were constructed through use of
the Kaplan–Meier method. Survival analysis was conducted
through both univariable and multivariable Cox regressions.
The variables chosen for the multivariable analysis were
age, sex, heart rate, mean arterial pressure, LAVI, and E/e0.
In order to assess the prognostic strength of examined
parameters, Harrell’s C-statistics were calculated for each
Cox regression model.
Results
Predictors of all-cause mortality in systolic heart
failure patients with atrial ﬁbrillation
During a median follow-up of 2.7 years, 40 patients (26.5%)
died. No clinical baseline characteristics were signiﬁcantly dif-
ferent between patients alive and patients dead at follow-up.
With regard to echocardiographic parameters, patients who
died had signiﬁcantly larger LAVI, signiﬁcantly lower TAPSE,
and signiﬁcantly lower values of GLSc, GCSc, and GCS. Among
parameters not reaching statistical signiﬁcance at baseline
were LVEF and GLS (Table 1).
Mean RR interval was 0.792 s (SD: 0.19 s), corresponding
to a mean heart rate of 80 b.p.m. (SD: 20 b.p.m.), and no sig-
niﬁcant difference in neither mean heart rate nor RR interval
between patients alive at follow-up and patients dead at
follow-up was found.
Stratiﬁcation of the population by tertiles of GLSc was per-
formed. Male gender was more frequent with decreasing
tertile of GLSc (Table 2). With regard to echocardiographic
parameters, decreasing tertile of GLSc was signiﬁcantly asso-
ciated with decreasing value of LVEF, increasing value of LV
internal diameter at end-diastole, increasing LV mass index,
shortened deceleration time, and lower TAPSE (Table 2).
Univariable Cox regression was carried out with parame-
ters that displayed statistical signiﬁcance at baseline (Table 3).
Signiﬁcant univariable predictors included GLSc, GCSc and
GCS, LAVI, and TAPSE. In multivariable models (age, sex,
mean arterial pressure, heart rate, LAVI, and E/e0), GLSc,
GCSc, and GCS remained signiﬁcant predictors of mortality
[GLSc: hazard ratio (HR) 1.17, 95% conﬁdence interval (CI)
1.05–1.31, P = 0.005, per %/s(1/2) decrease; GCSc: HR 1.19,
95% CI 1.06–1.33, P = 0.003, per %/s(1/2) decrease; and GCS:
HR 1.18, 95% CI 1.04–1.33, P = 0.011, per % decrease]
(Table 3). Neither LAVI nor TAPSE remained signiﬁcant
predictors in the multivariable analysis.
Each instance of (RR)^(1/2) correction provided an in-
crease in prognostic value as reﬂected in increased C-
statistics for GLSc and GCSc compared with those for GLS
and GCS. Both GCSc and GCS remained signiﬁcant after mul-
tivariable adjustment, but GCSc displayed markedly higher C-
statistics. GLSc displayed higher C-statistics than any other
parameters in the multivariable model (Table 3).
Cox regression with the population stratiﬁed into tertiles
of GLSc was carried out. In univariable analysis of GLSc
tertiles, patients in the lowest tertile displayed a three times
higher risk of dying than did the patients in the highest tertile
(ﬁrst tertile vs. third tertile, HR 3.00, 95% CI 1.37–6.60,
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P = 0.006) (Figure 1). After multivariable adjustment, the risk
was approximately four times higher and remained statisti-
cally signiﬁcant (ﬁrst tertile vs. third tertile, HR 3.8 95% CI
1.40–10.31, P = 0.009).
Discussion
Quantiﬁcation of LV function during AF rhythm presents a
signiﬁcant challenge due to a variety of factors such as a rapid
heart rate, a greatly increased beat-to-beat duration variabil-
ity (RR interval), and absence of the late diastolic velocity
wave (A, a0). These factors all partly disrupt the prognostic ef-
ﬁcacy of conventional echocardiographic parameters. These
phenomena are partly to blame for the relatively low amount
of knowledge accumulated in the scientiﬁc community with
regard to echocardiographic assessment of LV function in
AF patients. We propose that strain corrected by RR interval
{GLSc = GLS/[RR^(1/2)]} is a practical and superior strategy to
counterbalance the changing haemodynamics observed in
AF. This proposal is based on our ﬁndings tying decreasing
values of GLSc to a signiﬁcantly increased risk of death in
HFrEF patients displaying AF at echocardiographic
examination.
Varying cycle length observed in atrial ﬁbrillation
Counteraction of the cycle length variability displayed in AF
rhythm has previously been attempted through averaging of
echocardiographic parameters from multiple consecutive
heart cycles, preferably 5–15.13,14 This strategy not only is
cumbersome and time-consuming but also may run a risk of
negligence in a busy clinical setting due to its extensive na-
ture. As a response to this extensive nature of cardiac cycle
averaging, the index beat method has been proposed as an
alternative method and has been demonstrated to be supe-
rior to cardiac cycle averaging despite varying RR intervals.7,8
The index beat method is dependent on the pre-preceding
Table 1 Clinical and echocardiographic characteristics
All patients Alive at follow-up Dead at follow-up P-value
Clinical characteristics
n 151 111 40
Age (years) 70.5 (9.2) 69.7 (9.2) 72.5 (8.9) 0.10
Male 119 (78.8%) 87 (78.4%) 32 (80.0%) 0.83
Heart rate (b.p.m.) 80.3 (20.4) 80.4 (18.8) 80.0 (24.4) 0.91
BMI (kg/m2) 26.7 (5.1) 27.0 (5.0) 25.8 (5.5) 0.19
Diabetes mellitus 14 (9.2%) 12 (10.8%) 2 (5.0%) 0.28
MAP (mmHg) 93.4 (14.2) 93.5 (14.9) 93.2 (12.4) 0.93
Ischaemic cardiomyopathy 65 (43%) 50 (45.0%) 15 (37.5%) 0.41
Total cholesterol (mmol/L) 4.5 (1.0) 4.5 (1.0) 4.4 (1.1) 0.50
Angina pectoris 27 (18) 18 (16.2%) 9 (22.5%) 0.37
CABG 31 (21%) 26 (23.4%) 5 (12.5%) 0.14
Beta-blockers 104 (69%) 74 (66.7%) 30 (75.0%) 0.33
RAS blockade 125 (83%) 92 (82.9%) 33 (82.5%) 0.96
Diuretics 80 (53%) 60 (54.1%) 20 (50.0%) 0.66
Antiarrhythmics 8 (5.0%) 6 (5.4%) 2 (5.0%) 0.92
Calcium channel blocker 2 (1.0%) 2 (1.8%) 0 (0.0%) 0.39
Anticoagulants 2 (1.3%) 2 (1.8%) 0 (0.0%) 0.39
Spironolactone 17 (11.0%) 12 (10.8%) 5 (12.5%) 0.77
Echocardiography
LVEF (%) 26.2 (9.4) 27.1 (8.6) 23.7 (11.0) 0.053
RR interval (s) 0.792 (0.190) 0.890 (0.180) 0.810 (0.220) 0.47
LVIDd (cm) 5.7 (0.9) 5.6 (0.8) 5.7 (1.1) 0.50
LVMI (g/m2) 117.5 (32.4) 116.4 (33.1) 120.3 (30.6) 0.52
LAVI (mL/m2) 42.1 (19.0) 40.2 (15.3) 47.5 (26.0) 0.035
E (m/s) 0.97 (0.300) 0.97 (0.306) 0.96 (0.281) 0.93
e0 (m/s) 0.086 (0.026) 0.087 (0.027) 0.082 (0.021) 0.32
E/e0 11.9 (5.3) 11.8 (5.39) 12.4 (5.00) 0.57
DT (ms) 159 (61) 160 (54) 159 (75) 0.93
TAPSE (cm) 1.6 (0.5) 1.6 (0.5) 1.4 (0.5) 0.016
GLS (%) 10.1 (3.6) 10.5 (3.4) 9.2 (3.9) 0.056
GCS (%) 9.3 (3.5) 9.7 (3.6) 8.1 (2.9) 0.022
GLSc (%/s(1/2)) 11.4 (3.9) 11.8 (3.7) 10.2 (4.3) 0.022
GCSc (%/s(1/2)) 10.5 (4.2) 11.1 (4.2) 8.9 (3.7) 0.007
BMI, body mass index; CABG, coronary artery bypass grafting; DT, E-wave deceleration time; GCS, global circumferential strain; GCSc, RR-
corrected global circumferential strain {GCSc = GCS/[RR^(1/2)]}; GLS, global longitudinal strain; GLSc, RR-corrected global longitudinal
strain {GLSc = GLS/[RR^(1/2)]}; LAVI, left atrial volume index; LVEF, left ventricular ejection fraction; LVIDd, left ventricular internal diam-
eter at end-diastole; LVMI, left ventricular mass index; MAP, mean arterial pressure; RAS, renin–angiotensin system; TAPSE, tricuspid an-
nular plane systolic excursion.
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Table 2 Clinical and echocardiographic characteristics by tertiles of GLSc
Lowest tertile
GLSc < 9.5%/s(1/2)
Middle tertile
GLSc = 9.5–12.8%/s(1/2)
Highest tertile
GLSc > 12.8%/s(1/2) P-value for trend
Clinical characteristics
n 50 50 51
Age (years) 69.7 (8.5) 71.5 (8.5) 70.1 (10.4) 0.82
Male 46 (92%) 39 (78%) 34 (67%) 0.002
Heart rate (b.p.m.) 82.1 (24.0) 79.2 (22.0) 79.5 (15.0) 0.52
BMI (kg/m2) 27.4 (5.5) 26.8 (4.6) 25.9 (5.1) 0.14
Diabetes mellitus 7 (14%) 6 (12%) 1 (2%) 0.08
MAP (mmHg) 92.6 (13.3) 93.5 (13.4) 94.0 (16.1) 0.62
Ischaemic cardiomyopathy 22 (44%) 24 (48%) 19 (37%) 0.49
Total cholesterol (mmol/L) 4.4 (1.1) 4.6 (1.0) 4.5 (1.0) 0.76
Angina pectoris 8 (16%) 10 (20%) 9 (18%) 0.83
CABG 11 (22%) 12 (24%) 8 (16%) 0.43
Beta-blockers 32 (64%) 35 (70%) 37 (73%) 0.36
RAS blockade 44 (88%) 37 (74%) 44 (86%) 0.83
Diuretics 25 (50%) 25 (50%) 30 (59%) 0.38
Antiarrhythmics 3 (6%) 2 (4%) 3 (6%) 0.98
Calcium channel blockers 1 (2%) 0 (0%) 1 (2%) 0.99
Anticoagulants 1 (2%) 1 (2%) 0 (0%) 0.38
Spironolactone 9 (18%) 4 (8%) 4 (8%) 0.11
Echocardiography
n 50 50 51
LVEF (%) 18.6 (7.1) 26.1 (7.5) 33.6 (6.8) <0.001
RR interval (s) 0.792 (0.211) 0.813 (0.203) 0.781 (0.150) 0.87
LVIDd (cm) 6.2 (0.9) 5.6 (0.75) 5.2 (0.8) <0.001
LVMI (g/m2) 125 (34) 122 (29) 105 (31.0) 0.001
LAVI (mL/m2) 46.6 (17.7) 40.0 (12.6) 40.1 (24.2) 0.08
E (m/s) 0.98 (0.25) 0.95 (0.29) 0.97 (0.36) 0.87
e0 (m/s) 0.080 (0.021) 0.091 (0.032) 0.100 (0.031) 0.035
E/e0 12.8 (5.3) 12.3 (6.3) 10.5 (3.8) 0.046
DT (ms) 137 (50) 160 (68) 182 (55) <0.001
TAPSE (cm) 1.5 (0.4) 1.5 (0.5) 1.8 (0.5) 0.002
GLS (%) 6.5 (1.9) 10.0 (1.5) 13.8 (2.2) <0.001
GCS (%) 7.9 (3.5) 9.5 (3.0) 10.5 (3.6) <0.001
GCSc (%/s(1/2)) 9.0 (3.7) 10.8 (3.8) 11.9 (4.5) 0.001
BMI, body mass index; CABG, coronary artery bypass grafting; DT, E-wave deceleration time; GCS, global circumferential strain; GCSc, RR-
corrected global circumferential strain {GCSc = GCS/[RR^(1/2)]}; GLS, global longitudinal strain; GLSc, RR- corrected global longitudinal
strain {GLSc = GLS/[RR^(1/2)]}; LAVI, left atrial volume index; LVEF, left ventricular ejection fraction; LVIDd, left ventricular internal diam-
eter end-diastole; LVMI, left ventricular mass index; MAP, mean arterial pressure; RAS, renin–angiotensin system; TAPSE, tricuspid annular
plane systolic excursion.
Table 3 Cox regression models
Hazard ratio C-statistics P-value
Univariable
LAVI (per increasing mL/m2) HR 1.02, 95% CI 1.00–1.03 0.545 0.036
TAPSE (per increasing cm) HR 0.43, 95% CI 0.20–0.89 0.634 0.023
GCS (per decreasing %) HR 1.14, 95% CI 1.03–1.27, 0.636 0.015
GLSc (per decreasing %/s(1/2)) HR 1.12, 95% CI 1.02–1.22 0.636 0.014
GCSc (per decreasing %/s(1/2)) HR 1.14, 95% CI 1.04–1.26 0.645 0.006
Multivariable (age, sex, MAP, and heart rate)
LAVI (per increasing mL/m2) HR 1.01, 95% CI 1.00–1.03 0.601 0.081
TAPSE (per increasing cm) HR 0.46, 95% CI 0.21–0.98 0.642 0.045
GCS (per decreasing %) HR 1.18, 95% CI 1.04–1.33 0.659 0.011
GLSc (per decreasing %/s(1/2)) HR 1.17, 95% CI 1.05–1.31 0.681 0.005
GCSc (per decreasing %/s(1/2)) HR 1.19, 95% CI 1.06–1.33 0.671 0.003
Multivariable (age, sex, MAP, heart rate, LAVI, and E/e0)
TAPSE (per increasing cm) HR 0.46, 95% CI 0.20–1.06 0.625 0.068
GCS (per decreasing %) HR 1.18, 95% CI 1.04–1.33 0.659 0.011
GLSc (per decreasing %/s(1/2)) HR 1.17, 95% CI 1.05–1.31 0.681 0.005
GCSc (per decreasing %/s(1/2)) HR 1.19, 95% CI 1.06–1.33 0.671 0.003
CI, conﬁdence interval; GCS, global circumferential strain; GCSc, RR-corrected global circumferential strain {GCSc = GCS/[RR^(1/2)]};
GLSc, RR-corrected global longitudinal strain {GLSc = GLS/[RR^(1/2)]}; LAVI, left atrial volume index; MAP, mean arterial pressure; TAPSE,
tricuspid annular plane systolic excursion.
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RR interval and the preceding RR interval having a ratio of 1
(RR1/RR2 = 1). Obtainment of an RR1/RR2 = 1 sequence of
beats in any ﬁnite examination time is dependent on chance.
Hence, this calls for more research into a new and more ap-
plicable method to correct for the difﬁculties faced in
obtaining valid echocardiographic parameters from AF pa-
tients. Since neither cycle averaging nor index beat correction
can be applied in larger population studies with only one or
two heart cycles on record, and both are heavily dependent
on chance in addition to being time-consuming, a novel
method of cycle length indexation is needed.
Global longitudinal strain obtained by the index beat
method has been demonstrated as a signiﬁcant independent
prognosticator in patients with AF.15 Our study shows that
decreasing values of GLSc, thus values obtained from only a
single cycle, were signiﬁcantly associated with all-cause mor-
tality in patients with HFrEF displaying AF rhythm at examina-
tion. These results must be viewed in relation to the ﬁnding
that neither LVEF nor GLS was signiﬁcantly different between
patients who died during follow-up and patients who were
alive. Indexation of GLS by RR made GLSc a signiﬁcant predic-
tor at baseline, and it remained so in multivariable models.
Furthermore, GLSc displayed higher C-statistics than did all
other echocardiographic parameters in both univariable and
multivariable models. In addition to GLSc, we found that
GCS and GCS indexed by RR interval (GCSc) were also signiﬁ-
cant predictors of death, in both univariable and multivari-
able models. It must, however, be noted that GCS, and
therefore also GCSc, was only measured in a single echocar-
diographic view in this study, the parasternal short-axis view
at the mid-ventricular level. It does, however, provide indica-
tion that more research into the prognostic value of GCS and
GCSc with regard to prediction of outcome in HFrEF patients
with AF is warranted.
Justiﬁcation of RR interval indexation is further solidiﬁed
by results previously reported that GLSc correlated well when
obtained during sinus rhythm and AF measured in the same
patient, as opposed to uncorrected GLS and LVEF.7 It has also
recently been demonstrated that only GLSc, neither uncor-
rected GLS nor LVEF, remained an independent predictor af-
ter multivariate adjustment in AF patients without known HF,
when a composite endpoint was deﬁned as incidental HF,
stroke, myocardial infarction, and all-cause mortality.9
Taking the results of our study into consideration, RR inter-
val correction appears to emerge as a valid strategy to coun-
teract the varying haemodynamics observed in AF rhythm.
Atrial ﬁbrillation and heart failure
Research into methods of counteracting the haemodynamics
alterations from beat to beat in AF only becomes more im-
portant when the frequent coexistence of AF and HF is taken
into consideration.16,17 Effective quantiﬁcation of LV function
signiﬁcantly improves patient risk status and survival mainly
through intensiﬁed medical treatment and intervention.1,2
Our ﬁndings provide new insights into the prognostic value
of strain imaging indexed by the square root of the RR inter-
val in HFrEF patients with AF. These results therefore contrib-
ute to better risk stratiﬁcation of HFrEF patients with AF.
Limitations
Some limitations to the results of this study must be acknowl-
edged. Strain analysis was conducted ofﬂine, and all echocar-
diographic examinations were obtained in a routine clinical
setting—this increases the likelihood that suboptimal acous-
tic circumstances were accepted during examination. In our
view, potential inclusion of suboptimal echocardiographic ex-
aminations would only serve to weaken any found associa-
tions and hence reinforces the signiﬁcance of our results. In
addition, a risk of selection bias must also be acknowledged.
Furthermore, only two-dimensional (2D) imaging was avail-
able in echocardiograms included in this study. Three-
dimensional (3D) speckle tracking echocardiography (3DSTE)
is emerging as a potentially superior method of LV quantiﬁca-
tion.18 Both longitudinal strain and circumferential strain pa-
rameters derived from 3DSTE have been shown to be
different and more accurate than strain parameters derived
from 2D speckle tracking (2DSTE).18 3DSTE has also been
shown to be a superior method of quantifying LV twist and
torsion compared with 2DSTE.19 2DSTE can display inferior
tracking because of speckles moving out of the imaging plane
Figure 1 The curves display the cumulative survival of the population
stratiﬁed into tertiles of corrected global longitudinal strain (GLSc) as a
function of time from examination. The red curve depicts the cumulative
survival of patients in the lowest tertile of GLSc. The green curve depicts
the cumulative survival of patients in the highest tertile of GLSc. The blue
curve depicts the cumulative survival of patients in the middle tertile of
GLSc. CI, conﬁdence interval; HR, hazard ratio.
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in the z-axis direction.18,20 This could potentially cause inade-
quate and incorrect measurement of 2DSTE strain parame-
ters. 3DSTE does not suffer from the issue of speckles
moving out of the imaging plane because of tracking of the
entire left ventricle. However, 3DSTE requires frame stitching
of multiple consecutive cardiac cycles,20 something that is in-
feasible in AF rhythm because of the highly irregular RR inter-
val displayed by patients in AF rhythm. Also, 3DSTE
techniques display lower frame rates than do 2DSTE tech-
niques, and given that AF patients display consistently higher
heart rates, the low frame is an issue. Hence, it remains to be
assessed whether uncorrected 3DSTE GLS is prognostic in
HFrEF patients displaying AF during examination. However,
if the technical limitations regarding 3DSTE can be overcome,
evaluation of the prognostic value of 3DSTE strain parameters
in HFrEF patients displaying AF rhythm would be of great in-
terest because of previously mentioned advantages of 3DSTE
compared with 2DSTE. Lastly, only one heart cycle in each
view was available for analysis in the included echocardio-
grams. Therefore, we were not able to determine RR variabil-
ity or the RR1/RR2 ratio surrounding the particularly cycle on
record in each view. As a result, LVEF was derived from two
cardiac cycles (apical four chamber and apical two chamber),
and GLS was derived from three cycles (apical four chamber,
apical two chamber, and apical long axis). Due to lack of mul-
tiple cardiac cycles in each view, we were not able to com-
pare the prognostic value of GLSc with that of GLS obtained
using the index beat method. By extension, future studies
are needed in order to validate our suggested approach
against the index beat method.
Conclusions
Decreasing GLSc {GLSc = GLS/[RR^(1/2)]}, but not GLS or
LVEF, was signiﬁcantly associated with increased risk of
all-cause mortality in HFrEF patients with AF and remained
an independent predictor after multivariable adjustment.
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